Chemical industry – Page 32
-
BusinessTransforming PET imaging with silicon
Fuzionaire Diagnostics can add Si–18F radiolabels to a variety of molecules quickly, easily and cheaply
-
OpinionWhat would a 1980s student make of modern research?
Nano- and macromolecular science might make for a shocking read in the launderette
-
BusinessLords criticise post-Brexit regulation plans
Current lack of preparedness risks ‘cliff-edge’ on exit day, committee warns
-
NewsAction plan launched to tackle gender inequality and bullying in chemistry
Bullying helpline and childcare grants among measures outlined in Royal Society of Chemistry report that reveals why chemistry has an equality problem
-
OpinionPassing through checkpoints
A new breed of cancer treatments highlights what’s possible when industry concentrates its efforts
-
ResearchWaste vegetable oils turned into chemicals for drugs and plastics
Dual catalytic system converts complex carboxylic acids into terminal alkenes
-
BusinessSmall biocides companies face uncertain fate
Cost and complexity of European law hampers innovation and excludes SMEs
-
BusinessCancer immunotherapy spreads rapidly
New approvals and expanded use for checkpoint inhibitor drugs illustrate the power of Nobel-winning science
-
-
RSC£50bn chemistry SME sector under threat from Brexit
Access to skills and funding ‘crucial’ to protect sector’s long-term future
-
OpinionThe projects drug companies wish they’d never started
Failures are common in drug research, but some are bigger than others
-
ResearchRemote controlled self-optimising flow synthesis
Online interface could allow virtual sharing of complex kit, and enable simple improvement of reaction conditions
-
ArticleContinuous manufacturing could revolutionise drug development
Continuous flow manufacturing of pharmaceuticals offer the flexibility to accelerate the drug development process
-
BusinessCleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold
-
BusinessNovartis to cut over 2000 jobs
Move exemplifies a wave of manufacturing cuts as pharma moves to more high-value, specialised medicines
-
OpinionHas Crispr’s patent battle run its course?
As the originators duke it out in court, their patents are becoming increasingly irrelevant
-
Business‘No deal’ Brexit guidance fails to reassure UK chemical industry
UK government issues guidance on chemical regulation and patent law if the UK leaves the EU without agreement
-
-
BusinessIndia moves to ban cocktail drugs
Government injunction on 328 fixed dose combinations is strongly opposed by manufacturers
-
